• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Meaningful use of pharmacogenetics.

作者信息

Ratain M J, Johnson J A

机构信息

Department of Medicine and Center for Personalized Therapeutics, The University of Chicago, Chicago, Illinois, USA.

Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, Gainesville, Florida, USA.

出版信息

Clin Pharmacol Ther. 2014 Dec;96(6):650-2. doi: 10.1038/clpt.2014.188.

DOI:10.1038/clpt.2014.188
PMID:25399712
Abstract
摘要

相似文献

1
Meaningful use of pharmacogenetics.药物遗传学的有效应用。
Clin Pharmacol Ther. 2014 Dec;96(6):650-2. doi: 10.1038/clpt.2014.188.
2
Prediction of in vivo clearance and associated variability of CYP2C19 substrates by genotypes in populations utilizing a pharmacogenetics-based mechanistic model.利用基于药物遗传学的机制模型，通过群体中的基因型预测CYP2C19底物的体内清除率及相关变异性。
Drug Metab Dispos. 2015 Jun;43(6):870-83. doi: 10.1124/dmd.114.061523. Epub 2015 Apr 6.
3
Pharmacogenomics of antiplatelet drugs.抗血小板药物的药物基因组学
Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):343-7. doi: 10.1182/asheducation-2014.1.343. Epub 2014 Nov 18.
4
Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial.CYP2C19 和 ABCB1 单核苷酸多态性对替格瑞洛与氯吡格雷治疗急性冠脉综合征结局的影响：PLATO 试验的遗传亚研究。
Lancet. 2010 Oct 16;376(9749):1320-8. doi: 10.1016/S0140-6736(10)61274-3.
5
Evaluation of the relationship between polymorphisms in CYP2C19 and the pharmacokinetics of omeprazole, pantoprazole and rabeprazole.CYP2C19基因多态性与奥美拉唑、泮托拉唑和雷贝拉唑药代动力学之间关系的评估。
Pharmacogenomics. 2014;15(15):1893-901. doi: 10.2217/pgs.14.141.
6
Incorporating pharmacogenetics into clinical practice: reality of a new tool in psychiatry. Current issues in clinical implementation.将药物遗传学纳入临床实践：精神病学新工具的现状。临床实施中的当前问题。
CNS Spectr. 2006 Mar;11(3 Suppl 3):8-12.
7
Pharmacogenomics of oral antiplatelet drugs.口服抗血小板药物的药物基因组学
Pharmacogenomics. 2014 Mar;15(4):509-28. doi: 10.2217/pgs.14.16.
8
Incorporating pharmacogenetics into clinical practice: reality of a new tool in psychiatry. Practical issues related to medication selection.将药物遗传学纳入临床实践：精神病学新工具的现状。与药物选择相关的实际问题。
CNS Spectr. 2006 Mar;11(3 Suppl 3):5-7.
9
Association of polymorphisms of CYP2C9, CYP2C19, and ABCB1, and activity of P-glycoprotein with response to anti-epileptic drugs.CYP2C9、CYP2C19和ABCB1基因多态性及P-糖蛋白活性与抗癫痫药物反应的相关性
J Postgrad Med. 2014 Jul-Sep;60(3):265-9. doi: 10.4103/0022-3859.138739.
10
CYP2C19 polymorphisms and coronary heart disease risk factors synergistically impact clopidogrel response variety after percutaneous coronary intervention.CYP2C19基因多态性与冠心病危险因素对经皮冠状动脉介入治疗后氯吡格雷反应多样性具有协同影响。
Coron Artery Dis. 2014 Aug;25(5):412-20. doi: 10.1097/MCA.0000000000000092.

引用本文的文献

1
Recommendations for pharmacogenetic testing in clinical practice guidelines in the US.美国临床实践指南中的药物遗传学检测推荐建议。
Am J Health Syst Pharm. 2024 Aug 12;81(16):672-683. doi: 10.1093/ajhp/zxae110.
2
Moving Pharmacogenetics Into Practice: It's All About the Evidence!将药物遗传学付诸实践：关键在于证据！
Clin Pharmacol Ther. 2021 Sep;110(3):649-661. doi: 10.1002/cpt.2327. Epub 2021 Jul 7.
3
Prevalence and types of inconsistencies in clinical pharmacogenetic recommendations among major U.S. sources.美国主要信息来源中临床药物遗传学建议的不一致性患病率及类型
NPJ Genom Med. 2020 Oct 30;5:48. doi: 10.1038/s41525-020-00156-7. eCollection 2020.
4
Does cardiology hold pharmacogenetics to an inconsistent standard? A comparison of evidence among recommendations.心脏病学对药物遗传学的标准是否不一致？建议之间的证据比较。
Pharmacogenomics. 2018 Oct;19(15):1203-1216. doi: 10.2217/pgs-2018-0097. Epub 2018 Sep 10.
5
Physicians' attitudes toward pharmacogenetic testing before and after pharmacogenetic education.药物遗传学教育前后医生对药物遗传学检测的态度。
Per Med. 2016 Mar;13(2):119-127. doi: 10.2217/pme.15.57. Epub 2016 Mar 1.
6
Review of the Reported Measures of Clinical Validity and Clinical Utility as Arguments for the Implementation of Pharmacogenetic Testing: A Case Study of Statin-Induced Muscle Toxicity.作为实施药物基因检测依据的临床有效性和临床实用性报告措施综述：以他汀类药物引起的肌肉毒性为例
Front Pharmacol. 2017 Aug 23;8:555. doi: 10.3389/fphar.2017.00555. eCollection 2017.
7
CYP2D6 Genetic Variation and Beta-Blocker Maintenance Dose in Patients with Heart Failure.CYP2D6 基因变异与心力衰竭患者β受体阻滞剂维持剂量。
Pharm Res. 2017 Aug;34(8):1615-1625. doi: 10.1007/s11095-017-2104-8. Epub 2017 Feb 8.
8
Evidence and resources to implement pharmacogenetic knowledge for precision medicine.实施精准医学药物遗传学知识的证据和资源。
Am J Health Syst Pharm. 2016 Dec 1;73(23):1977-1985. doi: 10.2146/ajhp150977.
9
Assessment of pharmacogenetic tests: presenting measures of clinical validity and potential population impact in association studies.药物遗传学检测评估：在关联研究中呈现临床有效性和潜在人群影响的指标
Pharmacogenomics J. 2017 Jul;17(4):386-392. doi: 10.1038/tpj.2016.34. Epub 2016 May 10.
10
Pharmacogenetic Risk Scores for Perindopril Clinical and Cost Effectiveness in Stable Coronary Artery Disease: When Are We Ready to Implement?培哚普利用于稳定型冠状动脉疾病临床及成本效益的药物遗传学风险评分：我们何时准备好实施？
J Am Heart Assoc. 2016 Mar 28;5(3):e003440. doi: 10.1161/JAHA.116.003440.